197 related articles for article (PubMed ID: 17397912)
1. Demographic and clinical characteristics of children and adolescents with severe or difficult-to-treat asthma.
Chipps BE; Szefler SJ; Simons FE; Haselkorn T; Mink DR; Deniz Y; Lee JH;
J Allergy Clin Immunol; 2007 May; 119(5):1156-63. PubMed ID: 17397912
[TBL] [Abstract][Full Text] [Related]
2. Design and baseline characteristics of the epidemiology and natural history of asthma: Outcomes and Treatment Regimens (TENOR) study: a large cohort of patients with severe or difficult-to-treat asthma.
Dolan CM; Fraher KE; Bleecker ER; Borish L; Chipps B; Hayden ML; Weiss S; Zheng B; Johnson C; Wenzel S;
Ann Allergy Asthma Immunol; 2004 Jan; 92(1):32-9. PubMed ID: 14756462
[TBL] [Abstract][Full Text] [Related]
3. Allergy, total serum immunoglobulin E, and airflow in children and adolescents in TENOR.
Haselkorn T; Szefler SJ; Simons FE; Zeiger RS; Mink DR; Chipps BE; Borish L; Wong DA;
Pediatr Allergy Immunol; 2010 Dec; 21(8):1157-65. PubMed ID: 20444153
[TBL] [Abstract][Full Text] [Related]
4. Aspirin sensitivity and severity of asthma: evidence for irreversible airway obstruction in patients with severe or difficult-to-treat asthma.
Mascia K; Haselkorn T; Deniz YM; Miller DP; Bleecker ER; Borish L;
J Allergy Clin Immunol; 2005 Nov; 116(5):970-5. PubMed ID: 16275362
[TBL] [Abstract][Full Text] [Related]
5. Forced expiratory volume in 1 second percentage improves the classification of severity among children with asthma.
Fuhlbrigge AL; Weiss ST; Kuntz KM; Paltiel AD;
Pediatrics; 2006 Aug; 118(2):e347-55. PubMed ID: 16864642
[TBL] [Abstract][Full Text] [Related]
6. Tolerability of a salmeterol xinafoate/fluticasone propionate hydrofluoroalkane metered-dose inhaler in adolescent and adult patients with persistent asthma: a 52-week, open-label, stratified, parallel-group, multicenter study.
Cowie RL; Boulet LP; Keith PK; Scott-Wilson CA; House KW; Dorinsky PM
Clin Ther; 2007 Jul; 29(7):1390-402. PubMed ID: 17825690
[TBL] [Abstract][Full Text] [Related]
7. Gender differences in IgE-mediated allergic asthma in the epidemiology and natural history of asthma: Outcomes and Treatment Regimens (TENOR) study.
Lee JH; Haselkorn T; Chipps BE; Miller DP; Wenzel SE;
J Asthma; 2006 Apr; 43(3):179-84. PubMed ID: 16754518
[TBL] [Abstract][Full Text] [Related]
8. Total serum IgE levels in a large cohort of patients with severe or difficult-to-treat asthma.
Borish L; Chipps B; Deniz Y; Gujrathi S; Zheng B; Dolan CM;
Ann Allergy Asthma Immunol; 2005 Sep; 95(3):247-53. PubMed ID: 16200815
[TBL] [Abstract][Full Text] [Related]
9. Factors associated with the control of severe asthma.
Hermosa JL; Sánchez CB; Rubio MC; Mínguez MM; Walther JL
J Asthma; 2010 Mar; 47(2):124-30. PubMed ID: 20170317
[TBL] [Abstract][Full Text] [Related]
10. Asthma in older adults: observations from the epidemiology and natural history of asthma: outcomes and treatment regimens (TENOR) study.
Slavin RG; Haselkorn T; Lee JH; Zheng B; Deniz Y; Wenzel SE;
Ann Allergy Asthma Immunol; 2006 Mar; 96(3):406-14. PubMed ID: 16597074
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and tolerability of salmeterol/fluticasone propionate versus montelukast in childhood asthma: A prospective, randomized, double-blind, double-dummy, parallel-group study.
Maspero J; Guerra F; Cuevas F; Gutierrez JP; Soto-Ramos M; Anderton S; Mechali D; Chan R; Pedersen S
Clin Ther; 2008 Aug; 30(8):1492-504. PubMed ID: 18803991
[TBL] [Abstract][Full Text] [Related]
12. A 12-week, multicenter, randomized, partially blinded, active-controlled, parallel-group study of budesonide inhalation suspension in adolescents and adults with moderate to severe persistent asthma previously receiving inhaled corticosteroids with a metered-dose or dry powder inhaler.
Murphy K; Noonan M; Silkoff PE; Uryniak T
Clin Ther; 2007 Jun; 29(6):1013-26. PubMed ID: 17692718
[TBL] [Abstract][Full Text] [Related]
13. Urban minority children with asthma: substantial morbidity, compromised quality and access to specialists, and the importance of poverty and specialty care.
Flores G; Snowden-Bridon C; Torres S; Perez R; Walter T; Brotanek J; Lin H; Tomany-Korman S
J Asthma; 2009 May; 46(4):392-8. PubMed ID: 19484676
[TBL] [Abstract][Full Text] [Related]
14. Determinants of lung function and airway hyperresponsiveness in asthmatic children.
Bisgaard H; Pedersen S; Anhøj J; Agertoft L; Hedlin G; Gulsvik A; Bjermer L; Carlsen KH; Nordvall L; Lundbäck B; Wennergren G; Werner S; Bønnelykke K; Weiss ST
Respir Med; 2007 Jul; 101(7):1477-82. PubMed ID: 17336509
[TBL] [Abstract][Full Text] [Related]
15. Effectiveness of omalizumab in patients with inadequately controlled severe persistent allergic asthma: an open-label study.
Niven R; Chung KF; Panahloo Z; Blogg M; Ayre G
Respir Med; 2008 Oct; 102(10):1371-8. PubMed ID: 18657960
[TBL] [Abstract][Full Text] [Related]
16. Determinants of asthma control in tertiary level in Turkey: a cross-sectional multicenter survey.
Turktas H; Mungan D; Uysal MA; Oguzulgen K;
J Asthma; 2010 Jun; 47(5):557-62. PubMed ID: 20560829
[TBL] [Abstract][Full Text] [Related]
17. Comparative study of budesonide inhalation suspension and montelukast in young children with mild persistent asthma.
Szefler SJ; Baker JW; Uryniak T; Goldman M; Silkoff PE
J Allergy Clin Immunol; 2007 Nov; 120(5):1043-50. PubMed ID: 17983871
[TBL] [Abstract][Full Text] [Related]
18. Portable spirometry during acute exacerbations of asthma in children.
Langhan ML; Spiro DM
J Asthma; 2009 Mar; 46(2):122-5. PubMed ID: 19253115
[TBL] [Abstract][Full Text] [Related]
19. Control of persistent asthma in Spain: associated factors.
Díez Jde M; Barcina C; Muñoz M; Leal M
J Asthma; 2008 Nov; 45(9):740-6. PubMed ID: 18972288
[TBL] [Abstract][Full Text] [Related]
20. TENOR risk score predicts healthcare in adults with severe or difficult-to-treat asthma.
Miller MK; Lee JH; Blanc PD; Pasta DJ; Gujrathi S; Barron H; Wenzel SE; Weiss ST;
Eur Respir J; 2006 Dec; 28(6):1145-55. PubMed ID: 16870656
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
